UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 5, 2023 4:30 P.M.
Form:
S-3
CIK:
0001460702
Company Name:
Qualigen Therapeutics, Inc.
File Number:
333-269088